Moreover, the BRE‐AB sensor showed excellent sensing performance in complex matrices (whole blood and plasma) and effectively quantify the LH concentrations in 40 clinical patients (6 healthy women, 4 ovarian cancer patients, 10 breast cancer patients, 10 healthy men, and 10 prostate cancer patients). Here, PLOD1 is linked to breast carcinoma.